Production (Stage)
Inspire Veterinary Partners, Inc.
IVP
$1.48
-$0.08-5.13%
NASDAQ
| 03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | |
|---|---|---|---|---|---|
| Revenue | 15.40M | 16.59M | 17.05M | 17.13M | 17.22M |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | 15.40M | 16.59M | 17.05M | 17.13M | 17.22M |
| Cost of Revenue | 12.50M | 13.30M | 14.15M | 13.79M | 13.66M |
| Gross Profit | 2.90M | 3.29M | 2.90M | 3.33M | 3.57M |
| SG&A Expenses | 10.99M | 11.42M | 10.27M | 10.84M | 10.51M |
| Depreciation & Amortization | 1.22M | 1.31M | 1.39M | 1.36M | 1.32M |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | 24.71M | 26.03M | 25.81M | 25.99M | 25.49M |
| Operating Income | -9.31M | -9.44M | -8.75M | -8.87M | -8.26M |
| Income Before Tax | -13.26M | -14.26M | -14.44M | -18.83M | -16.68M |
| Income Tax Expenses | -- | -- | -- | -- | -- |
| Earnings from Continuing Operations | -13.26 | -14.26 | -14.44 | -18.83 | -16.68 |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | -13.26M | -14.26M | -14.44M | -18.83M | -16.68M |
| EBIT | -9.31M | -9.44M | -8.75M | -8.87M | -8.26M |
| EBITDA | -8.04M | -8.10M | -7.39M | -7.53M | -6.96M |
| EPS Basic | -62.01 | -73.11 | -49.18 | -39.56 | -21.97 |
| Normalized Basic EPS | -34.48 | -38.50 | -25.81 | -19.00 | -10.81 |
| EPS Diluted | -62.01 | -73.11 | -49.18 | -39.56 | -21.97 |
| Normalized Diluted EPS | -34.48 | -38.50 | -25.81 | -19.00 | -10.81 |
| Average Basic Shares Outstanding | 943.70K | 877.30K | 711.50K | 348.70K | 155.80K |
| Average Diluted Shares Outstanding | 943.70K | 877.30K | 711.50K | 348.70K | 155.80K |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |